SCHEMBL16640636

SCHEMBL16640636

CCOC(=O)c1ccn(CCOCc2ccccc2)c(=O)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.43
MAPK14 Q16539 1/20 0.43
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 3/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
CYP3A4 P08684 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16640634 0.88 NOTUM (0.48) MAPK14ALDH1A1MAPTGAAHPGD
SCHEMBL19646278 0.88 ALDH1A1 (0.43) TSHRMAPK14KDM4EALDH1A1MAPT
SCHEMBL16415457 0.87 TSHR (0.48) TSHRKDM4EALDH1A1MAPTGAA
SCHEMBL29220666 0.79 CRHBP (0.43) TSHRKDM4EALDH1A1MAPTCYP3A4
SCHEMBL16745602 0.79 MAPT (0.46) TSHRKDM4EALDH1A1MAPTGAA
SCHEMBL16411434 0.76 NOTUM (0.62) TSHRALDH1A1MAPTGAAHPGD
SCHEMBL16640630 0.75 KMT2A (0.44) MAPK14ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL9918732 0.75 ALDH1A1 (0.47) TSHRKDM4EALDH1A1MAPTGAA
SCHEMBL19646277 0.75 HTT (0.42) MAPK14ALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL27938749 0.74 SMN1; SMN2 (0.57) TSHRKDM4EALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9827336-B2 Radio-pharmaceutical complexes BAYER AS (NO) 2017-11-28 US disclosed
US-20150147272-A1 RADIO-PHARMACEUTICAL COMPLEXES BAYER AS (NO) 2015-05-28 US disclosed
US-20150110817-A1 RADIO-PHARMACEUTICAL COMPLEXES BAYER AS (NO) 2015-04-23 US disclosed
US-20150104385-A1 RADIO-PHARMACEUTICAL COMPLEXES ALGETA ASA (NO) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150147272-A1 RADIO-PHARMACEUTICAL COMPLEXES HCAR3, TYRO3, HCAR1 TSHR 55/4885MAPK14 4656/4885KDM4E 3537/4885
US-20150104385-A1 RADIO-PHARMACEUTICAL COMPLEXES CD22, HAVCR2, CD2 TSHR 13/4885MAPK14 4708/4885KDM4E 4223/4885
US-20150110817-A1 RADIO-PHARMACEUTICAL COMPLEXES TSPO, TK1, HCAR1 TSHR 64/4885MAPK14 4737/4885KDM4E 3577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.